Business Wire

ASC24

7.2.2024 10:31:30 CET | Business Wire | Press release

Share
ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals. Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba. They will compete for prestigious awards including the Champion, Silver Prize, Group Competition Award, e Prize, and Highest LINPACK at the finals hosted by Shanghai University from April 9 to 13, 2024.

In response to the challenge posed by a large number of excellent teams, the ASC Organizing Committee, and Shanghai University have decided to accommodate 25 teams for the ASC24 Finals, setting a new record for the highest number of teams qualified for onsite finals since the inception of the ASC competition in 2012.

Among the finalists, Huazhong University of Science and Technology's team demonstrated an in-depth grasp of supercomputing knowledge and technologies. Through precise performance bottleneck analysis and innovative optimization methods, they achieved outstanding results. Their exceptional performance across all tasks secured them the top rank in the preliminary round.

The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg. Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.

The ASC24 preliminaries included two computational tasks: Large Language Model (LLM) Inference Optimization and Seepage Numerical Simulation. Numerous participating teams excelled, showcasing remarkable capabilities in exploring and innovating in supercomputing application analysis, performance optimization, and parallel strategy design.

In the Large Language Model (LLM) Inference Optimization Challenge, participating teams were assigned the task of building and refining inference engines using the widely used open-source LLM, LLaMA2. The main goal was to achieve high-throughput inference on sample datasets provided by the organizing committee. Teams contending for success were expected to showcase a thorough understanding and proficiency in common parallel methods applicable to LLMs. Furthermore, they were tasked with implementing various techniques to enhance the inference process.

The team from Huazhong University of Science and Technology developed an LLM inference engine that incorporated tensor parallelism, KVCache, and PagedAttention. Additionally, they implemented asynchronous pipelining in parallel to address the issue of incomplete loading of model parameters on a single server. Moreover, they deployed a distributed memory manager on each node to ensure load balancing and conducted numerous comparative experiments to identify the optimal optimization method. These efforts propelled them to achieve the highest score. On the other hand, the team from Friedrich-Alexander-University Erlangen-Nuremberg utilized a customized TensorRT-LLM engine for their cluster. Through various experiments, they determined that a batch size of 8 resulted in twice the throughput compared to a batch size of 1. By leveraging tensor parallelism and batched generation, they achieved good performance.

The Seepage Simulation Task in ASC24 was designed to delve into the intricate flow patterns and characteristics of multiphase fluids within porous media using the open-source software OpenCAEPoro. Participating teams were tasked with simulating the seepage of multiphase fluids, including oil, gas, and water, specifically in scenarios related to petroleum extraction, based on the dataset provided by the organizing committee. The challenge required teams to skillfully optimize large-scale parallel computing processes, with a focus on improving the computing performance and parallel efficiency of discrete algorithms.

The team from Qinghai University utilized common optimization methods, including function inlining, loop expansion, and operator fusion, after conducting a detailed analysis of the seepage simulation software OpenCAEPoro. They also implemented vectorization and memory access optimization to address computational bottleneck matrix assembly, resulting in highly effective optimization. Meanwhile, the National Tsing Hua University team conducted a comprehensive analysis of OpenCAEPoro, pinpointing the primary bottleneck for CPU parallelization. They leveraged optimized compiler flags and computing libraries to achieve the best performance.

About ASC

The ASC Student Supercomputer Challenge is the world's largest student supercomputer competition, sponsored and organized by the Asia Supercomputer Community with support from experts and institutions across Asia, Europe, and America. The main objectives of ASC are to encourage the exchange and training of young supercomputing talent from different countries, improve supercomputing applications and R&D capacity, boost the development of supercomputing, and promote technical and industrial innovation. The first ASC Student Supercomputer Challenge was held in 2012 and has since attracted over 10,000 undergraduates from all over the world. Learn more for ASC at http://www.asc-events.net/StudentChallenge/index.html.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240207108190/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 08:00:00 CET | Press release

Clinical and preclinical presentations reflect the company’s ongoing exploration of peripheral neuropathic pain Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greates

Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye